Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Ketavet (Veterinary)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 314Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmather Updates On Ketamine Development And Commercial
    Pharmather Updates On Ketamine Development And Commercial

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160310/0/en/PharmaTher-Provides-Corporate-Update-on-Ketamine-Development-and-Commercial-Strategy.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share
    Pharmather Sells Ketamine ANDA, Poised For $25M+ In Payments
    Pharmather Sells Ketamine ANDA, Poised For $25M+ In Payments

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159435/0/en/PharmaTher-Announces-Sale-of-Ketamine-ANDA-with-Potential-to-Generate-Over-US-25-Million-in-Milestone-and-Profit-Sharing-Payments.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Nrx Pharma Resubmits ANDA For Ketafree
    Nrx Pharma Resubmits ANDA For Ketafree

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157687/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Re-Files-Abbreviated-New-Drug-Application-ANDA-for-KETAFREE-Preservative-Free-IV-Ketamine.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Harrow To Acquire Melt Pharmaceuticals
    Harrow To Acquire Melt Pharmaceuticals

    26 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/26/3156941/0/en/Harrow-to-Acquire-Melt-Pharmaceuticals.html

    GLOBENEWSWIRE
    26 Sep 2025
    Share Share
    NRx Pharmaceuticals Implements Expanded Access for NRX-100
    NRx Pharmaceuticals Implements Expanded Access for NRX-100

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139980/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Announces-Expanded-Access-Policy-for-NRX-100-preservative-free-ketamine.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139203/0/en/PharmaTher-Provides-Corporate-Update-Following-FDA-Approval-of-Ketamine-KETARx.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share